EXH5:XETRA:XETRA-iShares STOXX Europe 600 Insurance UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 38.58

Change

0.00 (0.00)%

Market Cap

USD 0.30B

Volume

2.61K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.55 (-1.07%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.18 (-1.06%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.34 (-1.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.31 (-1.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.36 (-1.48%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.88 (-0.60%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

-0.52 (-1.17%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.59 (-1.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-3.94 (-0.73%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.26 (-1.15%)

USD 79.79B

ETFs Containing EXH5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.05% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.05% 75% C 74% C
Trailing 12 Months  
Capital Gain 15.87% 70% C- 71% C-
Dividend Return 0.42% 12% F 6% D-
Total Return 16.29% 71% C- 71% C-
Trailing 5 Years  
Capital Gain 22.67% 47% F 52% F
Dividend Return 12.39% 92% A 64% D
Total Return 35.06% 55% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 6.50% 60% D- 58% F
Dividend Return 8.80% 69% C- 66% D+
Total Return N/A 46% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 15.55% 34% F 46% F
Risk Adjusted Return 56.58% 63% D 66% D+
Market Capitalization 0.30B 56% F 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.